OBJECT: Clinical application of the convection-enhanced delivery (CED) technique is currently limited by low infusion speed and reflux of the delivered agent. The authors developed and evaluated a new step-design cannula to overcome present limitations and to introduce a rapid, reflux-free CED method for future clinical trials. METHODS: The CED of 0.4% trypan blue dye was performed in agarose gel to test cannula needles for distribution and reflux. Infusion rates ranging from 0.5 to 50 microl/minute were used. Agarose gel findings were translated into a study in rats and then in cynomolgus monkeys (Macacafascicularis) by using trypan blue and liposomes to confirm the efficacy of the reflux-free step-design cannula in vivo. Results of agarose gel studies showed reflux-free infusion with high flow rates using the step-design cannula. Data from the study in rats confirmed the agarose gel findings and also revealed increasing tissue damage at a flow rate above 5-microl/minute. Robust reflux-free delivery and distribution of liposomes was achieved using the step-design cannula in brains in both rats and nonhuman primates. CONCLUSIONS: The authors developed a new step-design cannula for CED that effectively prevents reflux in vivo and maximizes the distribution of agents delivered in the brain. Data in the present study show reflux-free infusion with a constant volume of distribution in the rat brain over a broad range of flow rates. Reflux-free delivery of liposomes into nonhuman primate brain was also established using the cannula. This step-design cannula may allow reflux-free distribution and shorten the duration of infusion in future clinical applications of CED in humans.
OBJECT: Clinical application of the convection-enhanced delivery (CED) technique is currently limited by low infusion speed and reflux of the delivered agent. The authors developed and evaluated a new step-design cannula to overcome present limitations and to introduce a rapid, reflux-free CED method for future clinical trials. METHODS: The CED of 0.4% trypan blue dye was performed in agarose gel to test cannula needles for distribution and reflux. Infusion rates ranging from 0.5 to 50 microl/minute were used. Agarose gel findings were translated into a study in rats and then in cynomolgus monkeys (Macacafascicularis) by using trypan blue and liposomes to confirm the efficacy of the reflux-free step-design cannula in vivo. Results of agarose gel studies showed reflux-free infusion with high flow rates using the step-design cannula. Data from the study in rats confirmed the agarose gel findings and also revealed increasing tissue damage at a flow rate above 5-microl/minute. Robust reflux-free delivery and distribution of liposomes was achieved using the step-design cannula in brains in both rats and nonhuman primates. CONCLUSIONS: The authors developed a new step-design cannula for CED that effectively prevents reflux in vivo and maximizes the distribution of agents delivered in the brain. Data in the present study show reflux-free infusion with a constant volume of distribution in the rat brain over a broad range of flow rates. Reflux-free delivery of liposomes into nonhuman primate brain was also established using the cannula. This step-design cannula may allow reflux-free distribution and shorten the duration of infusion in future clinical applications of CED in humans.
Authors: Russell R Lonser; Stuart Walbridge; Kayhan Garmestani; John A Butman; Hugh A Walters; Alexander O Vortmeyer; Paul F Morrison; Martin W Brechbiel; Edward H Oldfield Journal: J Neurosurg Date: 2002-10 Impact factor: 5.115
Authors: Zhi-Jian Chen; William C Broaddus; Raju R Viswanathan; Raghu Raghavan; George T Gillies Journal: IEEE Trans Biomed Eng Date: 2002-02 Impact factor: 4.538
Authors: Steven S Gill; Nikunj K Patel; Gary R Hotton; Karen O'Sullivan; Renée McCarter; Martin Bunnage; David J Brooks; Clive N Svendsen; Peter Heywood Journal: Nat Med Date: 2003-03-31 Impact factor: 53.440
Authors: Ryuta Saito; John R Bringas; Tracy R McKnight; Michael F Wendland; Christoph Mamot; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krys S Bankiewicz Journal: Cancer Res Date: 2004-04-01 Impact factor: 12.701
Authors: Christoph Mamot; John B Nguyen; Micheal Pourdehnad; Piotr Hadaczek; Ryuta Saito; John R Bringas; Daryl C Drummond; Keelung Hong; Dmitri B Kirpotin; Tracy McKnight; Mitchel S Berger; John W Park; Krys S Bankiewicz Journal: J Neurooncol Date: 2004-05 Impact factor: 4.130
Authors: Jeffrey W Degen; Stuart Walbridge; Alexander O Vortmeyer; Edward H Oldfield; Russell R Lonser Journal: J Neurosurg Date: 2003-11 Impact factor: 5.115
Authors: Jung Hwan Kim; Garrett W Astary; Tatiana L Nobrega; Svetlana Kantorovich; Paul R Carney; Thomas H Mareci; Malisa Sarntinoranont Journal: J Neurosci Methods Date: 2012-06-08 Impact factor: 2.390
Authors: Michal T Krauze; Scott R Vandenberg; Yoji Yamashita; Ryuta Saito; John Forsayeth; Charles Noble; John Park; Krystof S Bankiewicz Journal: Exp Neurol Date: 2007-12-27 Impact factor: 5.330
Authors: Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz Journal: Neuroimage Date: 2008-11-27 Impact factor: 6.556
Authors: Waldy San Sebastian; Lluis Samaranch; Adrian P Kells; John Forsayeth; Krystof S Bankiewicz Journal: Neurotherapeutics Date: 2013-07 Impact factor: 7.620